Skip to main content

Table 4 Two-year and five-year survival for RIGS with 125I-B72.3 monoclonal antibody

From: A comprehensive overview of radioguided surgery using gamma detection probe technology

PATIENT

GROUP

SURVIVAL: 2-YEAR

(% PATIENTS)

SURVIVAL: 5-YEAR

(% PATIENTS)

RIGS resectable

95%

60%

Traditional nonresectable

36%

0%

RIGS nonresectable

57%

0%